Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation

被引:21
作者
Wang, Xudong [1 ]
Wang, Tianxi [1 ]
Lam, Enton [1 ]
Alvarez, David [2 ]
Sun, Ye [1 ]
机构
[1] Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
retina; immune privilege; inflammation; retinopathy of prematurity; age-related macular degeneration; diabetic retinopathy; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; PROLIFERATIVE DIABETIC-RETINOPATHY; JAK/STAT SIGNALING PATHWAY; PIGMENT EPITHELIAL-CELLS; REGULATORY T-CELLS; MACULAR DEGENERATION; AQUEOUS-HUMOR; NITRIC-OXIDE; MOUSE MODEL;
D O I
10.3390/ijms241512090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The eye is an immune privileged tissue that insulates the visual system from local and systemic immune provocation to preserve homeostatic functions of highly specialized retinal neural cells. If immune privilege is breached, immune stimuli will invade the eye and subsequently trigger acute inflammatory responses. Local resident microglia become active and release numerous immunological factors to protect the integrity of retinal neural cells. Although acute inflammatory responses are necessary to control and eradicate insults to the eye, chronic inflammation can cause retinal tissue damage and cell dysfunction, leading to ocular disease and vision loss. In this review, we summarized features of immune privilege in the retina and the key inflammatory responses, factors, and intracellular pathways activated when retinal immune privilege fails, as well as a highlight of the recent clinical and research advances in ocular immunity and ocular vascular diseases including retinopathy of prematurity, age-related macular degeneration, and diabetic retinopathy.
引用
收藏
页数:32
相关论文
共 379 条
  • [1] Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy
    Abu El-Asrar, Ahmed M.
    Struyf, Sofie
    Kangave, Dustan
    Geboes, Karel
    Van Damme, Jo
    [J]. EUROPEAN CYTOKINE NETWORK, 2006, 17 (03) : 155 - 165
  • [2] Interleukin-11 Overexpression and M2 Macrophage Density are Associated with Angiogenic Activity in Proliferative Diabetic Retinopathy
    Abu El-Asrar, Ahmed M.
    Ahmad, Ajmal
    Allegaert, Eef
    Siddiquei, Mohammad Mairaj
    Gikandi, Priscilla W.
    De Hertogh, Gert
    Opdenakker, Ghislain
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (04) : 575 - 588
  • [3] Cytokine Profiling in Patients With Exudative Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
    Agrawal, Rupesh
    Balne, Praveen Kumar
    Wei, Xin
    Bijin, Veonice Au
    Lee, Bernett
    Ghosh, Arkasubhra
    Narayanan, Raja
    Agrawal, Mukesh
    Connolly, John
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (01) : 376 - 382
  • [4] Targeting cyclooxygenases-1 and-2 in neuroinflammation: Therapeutic implications
    Aid, Saba
    Bosetti, Francesca
    [J]. BIOCHIMIE, 2011, 93 (01) : 46 - 51
  • [5] HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN RETINAL CELLS
    AIELLO, LP
    NORTHRUP, JM
    KEYT, BA
    TAKAGI, H
    IWAMOTO, MA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (12) : 1538 - 1544
  • [6] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [7] Contribution of TNF-α to the development of retinal neurodegenerative disorders
    Al-Gayyar, M. M.
    Elsherbiny, N. M.
    [J]. EUROPEAN CYTOKINE NETWORK, 2013, 24 (01) : 27 - 36
  • [8] Immunology of age-related macular degeneration
    Ambati, Jayakrishna
    Atkinson, John P.
    Gelfand, Bradley D.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (06) : 438 - 451
  • [9] iNOS as a metabolic enzyme under stress conditions
    Anavi, Sarit
    Tirosh, Oren
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2020, 146 : 16 - 35
  • [10] Mechanisms of Disease Diabetic Retinopathy
    Antonetti, David A.
    Klein, Ronald
    Gardner, Thomas W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13) : 1227 - 1239